The EVERY Co and Onego Bio Merger Talks
Alt-egg startups The EVERY Company and Onego Bio had been discussing a merger before talks fell apart and Onego sued its rival, court documents reveal.
The valuation figure was disclosed in a court filing, but the company has since asked the court to seal that information.
Patent Dispute
The EVERY Co has urged a court in Wisconsin to toss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents, which covers the production of ovalbumin via precision fermentation.
- The EVERY Co uses yeast (Komagataella phaffii) as its host microorganism.
- Onego Bio uses fungus (Trichoderma reesei).
The details of the talks were shared in an October 28 legal filing by The EVERY Co.
Author's summary: Merger talks between The EVERY Co and Onego Bio failed.